David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SDRL
1301
PUT
DELISTED
Seadrill Limited Common Stock
SDRL
| $5.52M | 0.01% |
2,203
-2,409
| -52% | -$6.99M |
|
|
INFO
1302
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $5.51M | 0.01% |
204,804
+134,950
| +193% | +$3.56M |
|
1303
Cooper-Standard Automotive
CPS
$474M
| $5.49M | 0.01% |
92,689
-6,442
| -6% | -$353K |
|
1304
CALL
Aflac
AFL
$58.2B
| $5.48M | 0.01% |
171,200
-333,800
| -66% | -$10.2M |
|
|
BWLD
1305
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $5.47M | 0.01% |
30,195
-21,864
| -42% | -$4.06M |
|
1306
Middleby
MIDD
$5.15B
| $5.45M | 0.01% |
53,102
+1,829
| +4% | +$186K |
|
1307
PUT
Colgate-Palmolive
CL
$72.8B
| $5.43M | 0.01% |
78,300
-67,700
| -46% | -$4.68M |
|
1308
CALL
Honeywell
HON
$68.4B
| $5.41M | 0.01% |
57,759
+10,572
| +22% | +$968K |
|
|
CKH
1309
DELISTED
Seacor Holdings Inc.
CKH
| $5.41M | 0.01% |
80,297
+27,892
| +53% | +$1.93M |
|
|
OME
1310
DELISTED
Omega Protein
OME
| $5.41M | 0.01% |
394,815
+55,923
| +17% | +$645K |
|
1311
PUT
NextEra Energy
NEE
$176B
| $5.39M | 0.01% |
207,200
-997,600
| -83% | -$26.3M |
|
1312
ICF International
ICFI
$1.58B
| $5.38M | 0.01% |
131,633
+1,181
| +0.9% | +$47.3K |
|
|
CBI
1313
DELISTED
Chicago Bridge & Iron Nv
CBI
| $5.37M | 0.01% |
109,068
-171,717
| -61% | -$7.22M |
|
|
SBNY
1314
DELISTED
Signature Bank
SBNY
| $5.37M | 0.01% |
41,466
+12,528
| +43% | +$1.56M |
|
|
FL
1315
PUT
DELISTED
Foot Locker
FL
| $5.36M | 0.01% |
85,000
-39,900
| -32% | -$2.26M |
|
1316
Enovis
ENOV
$1.48B
| $5.35M | 0.01% |
65,153
+52,371
| +410% | +$4.39M |
|
1317
Roper Technologies
ROP
$40.9B
| $5.34M | 0.01% |
31,069
+20,338
| +190% | +$3.29M |
|
1318
Newell Brands
NWL
$2.53B
| $5.34M | 0.01% |
136,759
-47,022
| -26% | -$1.81M |
|
|
ELX
1319
DELISTED
EMULEX CORP
ELX
| $5.34M | 0.01% |
670,059
+255,736
| +62% | +$1.79M |
|
1320
PUT
Wheaton Precious Metals
WPM
$74.4B
| $5.33M | 0.01% |
280,000
-458,200
| -62% | -$9.75M |
|
1321
CALL
Williams-Sonoma
WSM
$27.6B
| $5.33M | 0.01% |
133,600
-201,600
| -60% | -$7.99M |
|
1322
Biglari Holdings Class B
BH
$1.21B
| $5.32M | 0.01% |
19,272
+1,570
| +9% | +$441K |
|
1323
Mercer International
MERC
$28.6M
| $5.32M | 0.01% |
346,306
+14,378
| +4% | +$194K |
|
1324
AstraZeneca
AZN
$263B
| $5.32M | 0.01% |
+77,685
| New | +$5.4M |
|
|
AMRN
1325
Amarin Corp
AMRN
$299M
| $5.31M | 0.01% |
113,540
-61,743
| -35% | -$1.89M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.